Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Jan;3(1):10-5.
doi: 10.1159/000346857. Epub 2013 Feb 16.

Word list learning in patients with polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy

Affiliations

Word list learning in patients with polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy

Matti Vanhanen et al. Dement Geriatr Cogn Dis Extra. 2013 Jan.

Abstract

Background/aims: Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (PLOSL) is a rare hereditary disease that is characterized by a combination of progressive presenile dementia and sclerosing leukoencephalopathy with bone cysts. No quantitative information on verbal memory functioning in PLOSL patients compared with control subjects is available.

Methods: 23 patients with PLOSL and 23 control subjects were examined with a version of the 10-word list-learning task. Learning curves were compared between the patients and the matched control subjects.

Results: Compared with the control subjects, PLOSL patients with moderate or severe dementia were impaired in both learning trials and delayed recall on the 10-word list-learning test.

Conclusion: Progressive degeneration of brain structures affecting the hippocampus and the medial temporal lobe with advanced PLOSL disease contributes to an inefficient verbal learning process.

Keywords: Dementia; Frontal lobe degeneration; Nasu-Hakola disease; Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Mean number of learned words during 10 learning trials in PLOSL patients (●) and control subjects (○), according to the PLOSL severity of dementia.

Similar articles

References

    1. Hakola HP. Neuropsychiatric and genetic aspects of a new hereditary disease characterized by progressive dementia and lipomembranous polycystic osteodysplasia. Acta Psychiatr Scand Suppl. 1972;232:1–173. - PubMed
    1. Nasu T, Tsukahara Y, Terayama K. A libid metabolic disease – ‘membranous lipodystrophy’. Acta Pathol Jpn. 1973;23:539–558. - PubMed
    1. Paloneva J, Autti T, Raininko R, Partanen J, Salonen O, Puranen M, Hakola P, Haltia M. CNS manifestations of Nasu-Hakola disease: a frontal dementia with bone cysts. Neurology. 2001;56:1552–1558. - PubMed
    1. Hakola HP. Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (membranous lipodystrophy): a neuropsychiatric follow-up study. Monogr Psychiatr Fenn. 1990;17:1–114.
    1. Pekkarinen P, Kestilä M, Paloneva J, Terwilliger J, Varilo T, Järvi O, Hakola P, Peltonen L. Fine-scale mapping of a novel dementia gene, PLOSL, by linkage disequilibrium. Genomics. 1998;54:307–315. - PubMed

LinkOut - more resources